SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055771
Filing Date
2021-11-09
Accepted
2021-11-09 16:34:47
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pstx-10q_20210930.htm   iXBRL 10-Q 2787030
2 EX-10.2 pstx-ex102_416.htm EX-10.2 43087
3 EX-31.1 pstx-ex311_7.htm EX-31.1 17238
4 EX-31.2 pstx-ex312_9.htm EX-31.2 17222
5 EX-32.1 pstx-ex321_10.htm EX-32.1 7837
6 EX-32.2 pstx-ex322_8.htm EX-32.2 7819
  Complete submission text file 0001564590-21-055771.txt   8347327

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pstx-20210930.xsd EX-101.SCH 49820
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pstx-20210930_cal.xml EX-101.CAL 46700
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pstx-20210930_def.xml EX-101.DEF 201806
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstx-20210930_lab.xml EX-101.LAB 440776
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstx-20210930_pre.xml EX-101.PRE 322450
12 EXTRACTED XBRL INSTANCE DOCUMENT pstx-10q_20210930_htm.xml XML 1193383
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39376 | Film No.: 211392781
SIC: 2836 Biological Products, (No Diagnostic Substances)